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A powerful new Alzheimer's 
disease model 
Motivation
• The last new drug for Alzheimer’s was approved 
in 2003
• Dozens of clinical trials for new compounds have 
failed
• We badly need new disease models
• To understand the biology
• To link Alzheimer’s to the aging process
• To identify the targets for therapeutic intervention
Project Description
• The project combines the bioengineering 
expertise of the Benosman lab with the cell 
biological resources of the Herrup lab
• Cortical neurons will be grown on multielectrode arrays to 
establish neuronal networks in a dish
• A lenti virus will drive the expression of the Amyloid Precursor 
Protein (APP)
• The response of the network to the changes in the axon initial 
segment will be monitored 
The figure above shows the preliminary data supporting 
the shorten of the axon initial segment after APP 
expression.  The change would be predicted to make the 
neuron harder to fire and thus reduce network activity. 
Figure. Elevated  APP protein 
shortens the initial segment
Potential Impact
• Our disease models of Alzheimer’s 
disease have proven to be nearly 
worthless in interpretive and 
predictive value
• Proving the validity of our new 
model of APP function will offer a 
fresh and useful area to target new 
drugs and therapies.
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Context 
• The genetics of Alzheimer’s identifies APP as a 
disease gene.
• The field has assumed that the genetics meant that the 
beta-amyloid fragment of APP was driving Alzheimer’s 
disease
• We will test the alternative hypothesis that APP by way of 
its effect on the axon initial segment is the true driver of 
the disease
Project Deliverables
• Establish conditions for culturing neurons on the 
microelectrode array.
• Define the ground state behavior of the neural 
networks 
• Determine the effects of wild type and mutant 
APP expression on the network
• The preliminary data will be a springboard of 
preliminary data for competitive grant 
applications to NIH and NSF
• The network properties will serve as an advanced 
drug screening platform
• The network changes we observe will be validated in 
living animals
• The predicted changes in the axon initial segment 
will be charted in human brain
